Abbott Laboratories (ABT) Stock Forecast & Price Target

ABT$108.52+1.27 +1.18%
Medical - DevicesLarge Cap
Compare
Market cap$187.95BEnterprise value$226.98BRevenue (TTM)$48.23BMarket positionTop 25%

Score

45
Neutral
Value
44
Quality
52
Growth
39

Abbott Laboratories price target

ABT
Low$112.00
Average$121.36
High$130.00
Upside vs current price+11.8%

The average target of $121.36 is +11.8% versus the current ABT price of $108.52.

Abbott Laboratories analyst ratings

RatingAnalysts
Strong buy5
Buy18
Hold5
Sell0
Strong sell0
ConsensusBuy

28 analysts cover ABT.

Abbott Laboratories EPS and revenue estimates

Published annual figures for ABT on this page are 2026 EPS $5.52, 2027 EPS $5.93. Coverage under three analysts is omitted.

Fiscal yearEPS estimateRevenue estimate
2026$5.52$49.99B
2027$5.93$53.68B

Is Abbott Laboratories a buy or sell?

Of the 28 analysts covering Abbott Laboratories, 23 rate it a buy (5 strong buy and 18 buy), 5 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The ABT consensus label is Buy, beside 23 buy-side ratings and 0 sell-side ratings.

The average target of $121.36 implies +11.8% versus the current price of $108.52.

The ABT rating block is 28 published views with a Buy label. It does not tell you whether to buy or sell.

Reading the Abbott Laboratories forecast

the Abbott Laboratories has a tight target cluster: $112.00 to $130.00, average $121.36.

The gap from the $108.52 price to the ABT average is +11.8%.

The ABT rating mix is lopsided rather than split: 23 of 28 analysts are on the buy side, 5 are at hold, and 0 are on the sell side, and the published consensus is Buy.

the Abbott Laboratories has seen more upgrades (2) than downgrades (1) lately.

ABT targets have not moved much: $121.00 recently, $122.67 across the quarter.

the Abbott Laboratories is followed by 28 analysts, so the range matters more than any one target.

Abbott Laboratories forecast questions

What is the ABT price target?

The published range for ABT is $112.00 to $130.00, with an average of $121.36. That average is +11.8% versus the current price of $108.52.

Is Abbott Laboratories a buy or sell?

Of the 28 analysts covering Abbott Laboratories, 23 rate it a buy, 5 rate it a hold, and 0 rate it a sell. The consensus is Buy, leaving ABT at 23 buy ratings, 5 holds, and 0 sells.

What is the EPS estimate for Abbott Laboratories?

Analyst EPS estimates for Abbott Laboratories: 2026 $5.52, 2027 $5.93.

What is the revenue estimate for Abbott Laboratories?

Analyst revenue estimates for Abbott Laboratories: 2026 $49.99B, 2027 $53.68B.

How many analysts cover ABT?

28 analysts cover ABT. Their consensus on ABT is Buy, across those 28.

ABT price $108.52 +1.27 +1.18%

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener